Sigmak Lifesciences supports pharmaceutical importers, distributors, and procurement agencies in Ethiopia with WHO-GMP sourced injectable formulations, active pharmaceutical ingredients, and specialty chemical intermediates. Ethiopia is one of Africa's largest countries by population, with pharmaceutical import and registration overseen by the Ethiopian Food and Drug Authority (EFDA).
The injectable portfolio addresses key therapeutic priorities in Ethiopia including anti-malarials, antibiotics, anti-TB agents, maternal and child health formulations, analgesics, and essential medicines across ampoule and vial formats. Documentation support includes COA, COPP, and dossier packages aligned with EFDA registration requirements.
Sigmak works with both private sector distributors and public sector procurement programs in Ethiopia, offering structured supply support for institutional and tender-based purchasing across the country's expanding healthcare network.